Loading...

Home
Stock
PBM

PBM News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

AI Strategies

AI Stock Picker
Swing Trading
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Monitor News

Compare

TradingView
SeekingAlpha

PBM News

Psyence BioMed Announces Share Consolidation Plan

22 hours agoNewsfilter

Psyence Biomedical (PBM) Announces 1-for-6.25 Reverse Stock Split Effective January 20, 2026

Jan 15 2026seekingalpha

Psyence BioMed Executes 1-for-6.25 Share Consolidation, Reducing Outstanding Shares to 1.02 Million

Jan 15 2026Globenewswire

Psyence Biomedical Approves 2026 Financial Strategy and Share Repurchase Program

Jan 12 2026Newsfilter

Psyence BioMed Becomes First Nasdaq Company to Produce GMP-Compliant Ibogaine HCl

Jan 05 2026Globenewswire

Psyence BioMed Achieves First GMP-Compliant High-Purity Ibogaine Production on Nasdaq

Jan 05 2026Newsfilter

Kraig Biocraft Laboratories Transitions to Spider Silk Commercialization with 22% Yield Increase

Dec 19 2025Newsfilter

Psyence Biomedical Receives Approval for NPX5 in Phase IIb Clinical Trial

Dec 19 2025Globenewswire

PBM Events

Psyence Biomedical Ltd Trading Halted, News Pending

Psyence Biomedical Ltd trading halted, news pending

PBM Monitor News

Psyence Biomedical Ltd. stock rises after crossing above SMA

Psyence Biomedical achieves GMP-compliant ibogaine production

Psyence Biomedical achieves GMP-compliant ibogaine production

Psyence Biomedical Ltd rises amid sector rotation

Psyence Biomedical receives approval for NPX5 in Phase IIb trial

Psyence Biomedical Ltd surges on market strength

Psyence Biomedical Ltd Surges on Clinical Trial Progress

PBM.O Hits 52-Week Low Amid Market Volatility

PBM Earnings Analysis

an image of No Data

No Data

People Also Watch